MedPath

Long-term Adverse Effects After Bariatric Surgery on Bone Density

Not Applicable
Completed
Conditions
Morbid Obesity
Registration Number
NCT03410459
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

The goal of this trial is to examine long-term effects of laparoscopic gastric bypass (LRYGB) and sleeve gastrectomy (LSG) on bone mineral density, fracture risk, and body composition ≥ 5 years post-surgery.

Detailed Description

Bariatric surgery shows impressive results in terms of weight loss and resolution of comorbidities. Still, there are questions as to the frequency of long-term adverse effects: data on alterations in bone health are missing,

The goal of this trial is to examine long-term effects of laparoscopic gastric bypass (LRYGB) and sleeve gastrectomy (LSG) on bone mineral density, fracture risk, and body composition ≥ 5 years post-surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
140
Inclusion Criteria
  • Patients who received laparoscopic sleeve gastrectomy (LSG) or laparoscopic gastric bypass (LRYGB) ≥ 5 years ago as a primary bariatric procedure will be eligible for this study.
Exclusion Criteria
  • LSG or LRYGB as a secondary bariatric procedure (e.g. after gastric banding), patients receiving secondary bariatric operation after LSG resp LRYGB (e.g. biliopancreatic diversion), pregnancy (due to radiation exposition)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Total hip T-Score measured with dual-energy x-ray absorptiometry5-7 years after bariatric surgery

measured score will be compared to reference score for this age

Secondary Outcome Measures
NameTimeMethod
Total vertebral T-Score measured with dual-energy x-ray absorptiometry5-7 years after bariatric surgery

measured score will be compared to reference score for this age

fracture risk assessed by FRAX score5-7 years after bariatric surgery

measured score will be compared to reference score for this age

plasma concentration of C-terminal telopeptide (CTX)5-7 years after bariatric surgery

measured plasma concentration will be compared to reference for this age

plasma concentration of vitamin D35-7 years after bariatric surgery

measured plasma concentration will be compared to reference for this age

Trial Locations

Locations (1)

St Claraspital

🇨🇭

Basel, Switzerland

St Claraspital
🇨🇭Basel, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.